Tata Chemicals Share Price
Sector: Chemical Manufacturing
838.50 +12.15 (1.47%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
824.65
Today’s High
841.40
52 Week Low
756.45
52 Week High
1244.70
838.65 +12.20 (1.48%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
824.05
Today’s High
841.75
52 Week Low
756.00
52 Week High
1247.35
Key Metrics
- Market Cap (In Cr) 21361.32
- Beta 1.44
- Div. Yield (%) 1.81
- P/B 0.95
- TTM P/E -
- Peg Ratio -
- Sector P/E 17.96
- Open Price 828.8
- Prev Close 826.35
Tata Chemicals Analysis
Price Analysis
-
1 Week-2.63%
-
3 Months-13.63%
-
6 Month-22.38%
-
YTD-21.46%
-
1 Year-25.73%
Risk Meter
- 27% Low risk
- 27% Moderate risk
- 27% Balanced Risk
- 27% High risk
- 27% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 1
- 1
- 1
- 0.00
- Hold
- 1
- 1
- 1
- 1
- Sell
- 4
- 4
- 4
- 5
- Strong Sell
- 1
- 1
- 1
- 1
- Total
- 7
- 7
- 7
- 7
Tata Chemicals News
Q4 results today: LTIMindtree, Tata Consumer, Bajaj Housing to declare earnings
2 min read . 23 Apr 2025Nagaraj Shetti of HDFC Sec suggests these 2 stocks to buy or sell for short-term
2 min read . 07 Apr 2025Stocks to buy for long-term: TCS, ITC among top picks amid falling market
2 min read . 04 Mar 2025Tata Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 15421
- Selling/ General/ Admin Expenses Total
- 5159
- Depreciation/ Amortization
- 979
- Other Operating Expenses Total
- 796
- Total Operating Expense
- 14325
- Operating Income
- 1096
- Net Income Before Taxes
- 830
- Net Income
- 268
- Diluted Normalized EPS
- 29.61
- Period
- 2024
- Total Assets
- 36756
- Total Liabilities
- 14515
- Total Equity
- 22241
- Tangible Book Valueper Share Common Eq
- 456.99
- Period
- 2024
- Cashfrom Operating Activities
- 3016
- Cashfrom Investing Activities
- -610
- Cashfrom Financing Activities
- -2494
- Net Changein Cash
- -83
- Period
- 2023
- Total Revenue
- 16789
- Selling/ General/ Admin Expenses Total
- 4764
- Depreciation/ Amortization
- 890
- Other Operating Expenses Total
- 661
- Total Operating Expense
- 13772
- Operating Income
- 3017
- Net Income Before Taxes
- 2740
- Net Income
- 2317
- Diluted Normalized EPS
- 93.69
- Period
- 2023
- Total Assets
- 35084
- Total Liabilities
- 15363
- Total Equity
- 19721
- Tangible Book Valueper Share Common Eq
- 360.78
- Period
- 2023
- Cashfrom Operating Activities
- 2971
- Cashfrom Investing Activities
- -1186
- Cashfrom Financing Activities
- -2076
- Net Changein Cash
- -254
- Period
- 2022
- Total Revenue
- 12622.12
- Selling/ General/ Admin Expenses Total
- 4024.72
- Depreciation/ Amortization
- 804.92
- Other Operating Expenses Total
- 482.52
- Total Operating Expense
- 11085.09
- Operating Income
- 1537.03
- Net Income Before Taxes
- 1666.63
- Net Income
- 1257.62
- Diluted Normalized EPS
- 50
- Period
- 2022
- Total Assets
- 33843.27
- Total Liabilities
- 15590.38
- Total Equity
- 18252.89
- Tangible Book Valueper Share Common Eq
- 329.14
- Period
- 2022
- Cashfrom Operating Activities
- 1644.33
- Cashfrom Investing Activities
- -836.14
- Cashfrom Financing Activities
- -755.25
- Net Changein Cash
- 72.19
- Period
- 2021
- Total Revenue
- 10199.8
- Selling/ General/ Admin Expenses Total
- 3496.03
- Depreciation/ Amortization
- 758.71
- Other Operating Expenses Total
- 509.78
- Total Operating Expense
- 9388.25
- Operating Income
- 811.55
- Net Income Before Taxes
- 633.99
- Net Income
- 256.37
- Diluted Normalized EPS
- 10.22
- Period
- 2021
- Total Assets
- 28337.2
- Total Liabilities
- 14047.23
- Total Equity
- 14289.97
- Tangible Book Valueper Share Common Eq
- 183.29
- Period
- 2021
- Cashfrom Operating Activities
- 2037.3
- Cashfrom Investing Activities
- -1130.31
- Cashfrom Financing Activities
- -1455.65
- Net Changein Cash
- -564.92
- Period
- 2020
- Total Revenue
- 10356.75
- Selling/ General/ Admin Expenses Total
- 3599.2
- Depreciation/ Amortization
- 665.81
- Other Operating Expenses Total
- 557.54
- Total Operating Expense
- 9035.73
- Operating Income
- 1321.02
- Net Income Before Taxes
- 1248.06
- Net Income
- 7006.33
- Diluted Normalized EPS
- 31.17
- Period
- 2020
- Total Assets
- 27688.75
- Total Liabilities
- 14791.09
- Total Equity
- 12897.66
- Tangible Book Valueper Share Common Eq
- 113.76
- Period
- 2020
- Cashfrom Operating Activities
- 1780.09
- Cashfrom Investing Activities
- -2368.23
- Cashfrom Financing Activities
- -129.26
- Net Changein Cash
- -634.12
- Period
- 2019
- Total Revenue
- 10336.72
- Selling/ General/ Admin Expenses Total
- 3627.51
- Depreciation/ Amortization
- 567.77
- Other Operating Expenses Total
- 583.43
- Total Operating Expense
- 9015.02
- Operating Income
- 1321.7
- Net Income Before Taxes
- 1437.26
- Net Income
- 1155.91
- Diluted Normalized EPS
- 34.92
- Period
- 2019
- Total Assets
- 26904.92
- Total Liabilities
- 14563.65
- Total Equity
- 12341.27
- Tangible Book Valueper Share Common Eq
- 120.62
- Period
- 2019
- Cashfrom Operating Activities
- 1582.33
- Cashfrom Investing Activities
- -1958.19
- Cashfrom Financing Activities
- -1711.83
- Net Changein Cash
- -2057.55
- Period
- 2024-12-31
- Total Revenue
- 3590
- Selling/ General/ Admin Expenses Total
- 1172
- Depreciation/ Amortization
- 280
- Other Operating Expenses Total
- 780
- Total Operating Expense
- 3506
- Operating Income
- 84
- Net Income Before Taxes
- -4
- Net Income
- -53
- Diluted Normalized EPS
- -0.29
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 3999
- Selling/ General/ Admin Expenses Total
- 1190
- Depreciation/ Amortization
- 277
- Other Operating Expenses Total
- 743
- Total Operating Expense
- 3658
- Operating Income
- 341
- Net Income Before Taxes
- 348
- Net Income
- 194
- Diluted Normalized EPS
- 7.61
- Period
- 2024-09-30
- Total Assets
- 37621
- Total Liabilities
- 15426
- Total Equity
- 22195
- Tangible Book Valueper Share Common Eq
- 453.49
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 673
- Cashfrom Investing Activities
- -564
- Cashfrom Financing Activities
- -91
- Net Changein Cash
- 25
- Period
- 2024-06-30
- Total Revenue
- 3789
- Selling/ General/ Admin Expenses Total
- 1144
- Depreciation/ Amortization
- 273
- Other Operating Expenses Total
- 726
- Total Operating Expense
- 3488
- Operating Income
- 301
- Net Income Before Taxes
- 269
- Net Income
- 150
- Diluted Normalized EPS
- 5.3
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 3475
- Selling/ General/ Admin Expenses Total
- 1139
- Depreciation/ Amortization
- 271
- Other Operating Expenses Total
- 783
- Total Operating Expense
- 4266
- Operating Income
- -791
- Net Income Before Taxes
- -796
- Net Income
- -850
- Diluted Normalized EPS
- -7.89
- Period
- 2024-03-31
- Total Assets
- 36756
- Total Liabilities
- 14515
- Total Equity
- 22241
- Tangible Book Valueper Share Common Eq
- 456.99
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 3016
- Cashfrom Investing Activities
- -610
- Cashfrom Financing Activities
- -2494
- Net Changein Cash
- -83
- Period
- 2023-12-31
- Total Revenue
- 3730
- Selling/ General/ Admin Expenses Total
- 1025
- Depreciation/ Amortization
- 246
- Other Operating Expenses Total
- 761
- Total Operating Expense
- 3434
- Operating Income
- 296
- Net Income Before Taxes
- 262
- Net Income
- 158
- Diluted Normalized EPS
- 6.2
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 3998
- Selling/ General/ Admin Expenses Total
- 977
- Depreciation/ Amortization
- 234
- Other Operating Expenses Total
- 731
- Total Operating Expense
- 3311
- Operating Income
- 687
- Net Income Before Taxes
- 615
- Net Income
- 428
- Diluted Normalized EPS
- 13.58
- Period
- 2023-09-30
- Total Assets
- 35907
- Total Liabilities
- 14504
- Total Equity
- 21403
- Tangible Book Valueper Share Common Eq
- 424.64
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 1493
- Cashfrom Investing Activities
- 223
- Cashfrom Financing Activities
- -1597
- Net Changein Cash
- 123
- Period
- 2023-06-30
- Total Revenue
- 4218
- Selling/ General/ Admin Expenses Total
- 987
- Depreciation/ Amortization
- 229
- Other Operating Expenses Total
- 797
- Total Operating Expense
- 3404
- Operating Income
- 814
- Net Income Before Taxes
- 749
- Net Income
- 532
- Diluted Normalized EPS
- 20.53
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 4407
- Selling/ General/ Admin Expenses Total
- 1044
- Depreciation/ Amortization
- 234
- Other Operating Expenses Total
- 804
- Total Operating Expense
- 3676
- Operating Income
- 731
- Net Income Before Taxes
- 686
- Net Income
- 709
- Diluted Normalized EPS
- 28.67
- Period
- 2023-03-31
- Total Assets
- 35084
- Total Liabilities
- 15363
- Total Equity
- 19721
- Tangible Book Valueper Share Common Eq
- 360.78
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 2971
- Cashfrom Investing Activities
- -1186
- Cashfrom Financing Activities
- -2076
- Net Changein Cash
- -254
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Tata Chemicals Technical
Moving Average
SMA
- 5 Day850.78
- 10 Day844.09
- 20 Day841.4
- 50 Day837.54
- 100 Day931.59
- 300 Day1006.44
Tata Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Bayer Cropscience
- 4785
- -106.2
- -2.17
- 7189.9
- 4220.05
- 21620.38
- Kansai Nerolac Paints
- 260.9
- -1.1
- -0.42
- 320.65
- 218.35
- 21104.41
- Tata Chemicals
- 838.5
- 12.15
- 1.47
- 1244.7
- 756.45
- 21361.32
- Basf India
- 4482.2
- -40.95
- -0.91
- 8748.1
- 3539
- 19445.12
- Atul
- 6514
- 102.65
- 1.6
- 8165.25
- 4882
- 19200.37
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Bayer Cropscience
- 29.06
- 7.72
- 24.11
- 13.62
- Kansai Nerolac Paints
- 30.87
- 3.8
- 14.63
- 9.45
- Tata Chemicals
- 27.91
- 0.95
- 5.98
- 8.82
- Basf India
- 34.84
- 6.08
- 20.57
- 3.7
- Atul
- 39.02
- 3.38
- 11.51
- 10.57
Tata Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 03-Feb-25
- Quarterly Results
- 17-Oct-24
- Quarterly Results
- 05-Aug-24
- Quarterly Results
- 29-Apr-24
- Audited Results, Dividend & Others
- 05-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 03-May-23
- Audited Results & Final Dividend
- 01-Feb-23
- Quarterly Results
- 27-Oct-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 26-Jun-24
- 21-May-24
- AGM
- 26-Jun-23
- 16-May-23
- AGM
- 25-Mar-23
- 21-Feb-23
- POM
- 06-Jul-22
- 29-Apr-22
- AGM
- 02-Jul-21
- 03-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 29-Apr-24
- 12-Jun-24
- 12-Jun-24
- 15
- 03-May-23
- -
- 14-Jun-23
- 17.5
- 29-Apr-22
- -
- 15-Jun-22
- 12.5
- 03-May-21
- -
- 14-Jun-21
- 10


